MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: SchuheBloch BallettschläppchenAntwortenAntworten: Bloch Ballettschläppchen <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 11:10 Uhr</div>Hello! This post was created with XRumer 23 StrongAI. Good luck :) https://tsn.ua/ru [url=https://www.nba.com/ ]Basketball5[/url] variant3 [url=]Zoya Demidenko[/url]: Scientist in Oncology Studies [url=]Zoya Demidenko[/url] is a prominent scientist associated with the Division of Cell Stress Research at Roswell Park Oncology Institute in Buffalo, New York. Previously, she was employed at the National Institutes of Health and New York Medical College, developing a strong background in clinical study. Demidenko's scholarly work covers several critical areas, among them the PI3K/AKT/mTOR signaling pathway, cell cycle regulation, biological aging, and cancer science. To date, she has authored over 46 peer-reviewed articles, which have received upwards of 4,100 mentions — a reflection to the significance of her research. Among her key achievements involves elucidating the processes of cell aging. Her work demonstrated that when the cell cycle is blocked while cellular growth proceeds, the cells enter senescence. Importantly, [url=]Zoya Demidenko[/url] established that this process can be inhibited by medication using compounds such as mTOR inhibitors. [url=]Zoya Demidenko[/url] has furthermore brought greatly to oncological therapy investigation, especially in the area of cyclotherapy — a method aimed at safeguarding normal cells from cytotoxic treatment whilst leaving malignant cells exposed. This method offers considerable hope for diminishing the toxic effects of cancer treatment. Across her career, Demidenko has partnered with prominent investigators internationally, such as Dr. Mikhail Blagosklonny. Her publications appears in leading publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.</blockquote><br> Abbrechen
